Beneficient Income Taxes Disclosure
| Year Ended March 31, | ||||||||||||||
| (Dollars in thousands) | 2026 | 2025 | ||||||||||||
Current provision expense (benefit) | ||||||||||||||
| Federal | $ | 7 | $ | — | ||||||||||
State and local | 207 | 80 | ||||||||||||
Deferred provision expense (benefit) | ||||||||||||||
| Federal | $ | 35,860 | $ | 6,370 | ||||||||||
State and local | 105 | 743 | ||||||||||||
Valuation allowance | (35,965) | (7,113) | ||||||||||||
Income tax expense (benefit) | $ | 214 | $ | 80 | ||||||||||
| Year Ended March 31, 2026 | ||||||||||||||
| (Dollars in thousands) | Amount | % of Earnings (Loss) before Tax | ||||||||||||
| Earnings before income taxes (EBT) | $ | (164,516) | ||||||||||||
| US federal tax | (34,548) | 21.00 | % | |||||||||||
| State and local income taxes, net of federal income tax effect | ||||||||||||||
| Texas | 164 | (0.10) | % | |||||||||||
| Changes in valuation allowance | 35,964 | (21.86) | % | |||||||||||
| Nontaxable or nondeductible items | ||||||||||||||
| Goodwill and intangible assets impairment | 651 | (0.40) | % | |||||||||||
| Warrant/conversion derivative | (1,977) | 1.20 | % | |||||||||||
| Other | 48 | (0.02) | % | |||||||||||
| Other adjustments | (88) | 0.05 | % | |||||||||||
| Effective tax rate | $ | 214 | (0.13) | % | ||||||||||
| (Dollars in thousands) | Year Ended March 31, 2025 | |||||||
| Expected statutory income tax expense (benefit) | $ | (152) | ||||||
| Amounts not deductible for income tax - goodwill impairment | 775 | |||||||
| Amounts not deductible for income tax - other | 1,448 | |||||||
| Amounts attributable to non-taxable flow-through entities | 5,122 | |||||||
| Return to provision adjustment | 3,201 | |||||||
| Change in valuation allowance | (10,314) | |||||||
| Income tax expense | $ | 80 | ||||||
| (Dollars in thousands) | March 31, 2026 | March 31, 2025 | |||||||||
| Deferred income tax assets: | |||||||||||
| Passthrough differences - temporary | $ | 46,840 | $ | 30,112 | |||||||
| Loss on arbitration | 14,289 | — | |||||||||
Share-based compensation | 4,400 | 4,089 | |||||||||
| Net operating loss | 28,578 | 24,296 | |||||||||
Other | 517 | 163 | |||||||||
| Non-current deferred income tax assets | 94,624 | 58,660 | |||||||||
| Deferred income tax liabilities: | |||||||||||
| Other | — | — | |||||||||
| Non-current deferred income tax liabilities | — | — | |||||||||
| Less: valuation allowance | 94,624 | 58,660 | |||||||||
| Total deferred income tax liability | $ | — | $ | — | |||||||
Want the next Beneficient income taxes disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment Beneficient's next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2026 | Jun 30, 2026 | Showing above |
| 2025 | Sep 29, 2025 | |
| 2024 | Jul 9, 2024 | |
| 2023 | Jul 13, 2023 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.